Artificial Intelligence

A landmark acquisition pairs a powerful AI engine with deep human expertise, signaling a new era for how brands connect with diverse audiences.

How a services giant tamed 18,000 vendor records to slash risk and build a scalable foundation for future growth and AI-driven operations.

Global Database launches Regis, a free AI using live government data to answer business questions without hallucinations, challenging the BI establishment.

As electronica Shanghai 2026 expands, it's more than a trade show. It's a critical gauge of AI integration, supply chain resilience, and hybrid event models.

A $17B wealth manager is standardizing growth with an AI engine. We unpack how this deal signals a major shift from acquisitions to AI-driven organic growth.

European insurers are shifting BPO from a cost-saving tactic to a strategic tool for resilience, compliance, and AI readiness, reshaping the industry.

Amid geopolitical shocks and a cooling global economy, a new breed of technology is emerging not just to survive, but to thrive. We explore the innovations.

A landmark partnership between Duality and Capgemini aims to solve AI's biggest paradox: how to use valuable, private data without ever exposing it.

A record $139M for Dominion Dynamics isn't just about drones. It's a signal of Canada's strategic pivot to Arctic sovereignty and a new war for tech talent.

As its 'Gateway' transformation nears completion, UK bank Vanquis adopts Freshworks' AI to overhaul its internal engine. Here's what it means for banking.

New data reveals Europe's largest companies are closing the AI gap with North America, but a dangerous divide is opening at home, leaving smaller firms behind.

A new audit framework finds over half of medical AI research skills are unreliable. AIPOCH's MedSkillAudit aims to be the gatekeeper science has been waiting for.

EdgeCortix's AI platform just got a major green light from the Pentagon's innovation arm. What does this mean for the future of battlefield tech and space AI?

STARTRADER's new pre-IPO products for OpenAI and Anthropic offer early access to AI giants, but the path is paved with leverage, speculation, and risk.

With FDA clearance, Gain Therapeutics' GT-02287, an AI-discovered drug, advances to Phase 2, offering a new hope to modify Parkinson's, not just its symptoms.

As a 'silver tsunami' threatens critical industries, a new wearable aims to digitize the invaluable, unwritten knowledge of veteran workers before it's lost.

Cogent's divestment of 10 data centers to I Squared Capital isn't just a sale; it's a strategic realignment funding core growth and launching a new AI-focused platform.

Surgical Information Systems names Tim O'Brien CEO, signaling a major push into AI-driven workflows for the booming ambulatory surgery center (ASC) market.